Compare IRTC & SHOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRTC | SHOO |
|---|---|---|
| Founded | 2006 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Shoe Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.3B |
| IPO Year | 2016 | 1996 |
| Metric | IRTC | SHOO |
|---|---|---|
| Price | $121.92 | $42.75 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 9 |
| Target Price | ★ $171.33 | $52.11 |
| AVG Volume (30 Days) | 416.0K | ★ 926.8K |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 1.94% |
| EPS Growth | ★ 61.71 | N/A |
| EPS | N/A | ★ 1.38 |
| Revenue | $747,138,000.00 | ★ $2,534,109,000.00 |
| Revenue This Year | $19.35 | $13.54 |
| Revenue Next Year | $16.58 | $7.99 |
| P/E Ratio | ★ N/A | $31.35 |
| Revenue Growth | ★ 26.24 | 11.00 |
| 52 Week Low | $100.70 | $31.33 |
| 52 Week High | $210.01 | $49.70 |
| Indicator | IRTC | SHOO |
|---|---|---|
| Relative Strength Index (RSI) | 66.89 | 37.78 |
| Support Level | $113.82 | $41.11 |
| Resistance Level | $125.38 | $44.49 |
| Average True Range (ATR) | 3.99 | 1.40 |
| MACD | 1.98 | -0.27 |
| Stochastic Oscillator | 95.44 | 2.27 |
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
Steven Madden Ltd and its subsidiaries design, source, and market branded and private label footwear, accessories, and apparel. Its offerings include contemporary styles and core products, known for design creativity, trend-right offerings, high quality, and accessible price points. It operates through four segments: Wholesale Footwear, which generates maximum revenue and sells footwear globally; Wholesale Accessories/Apparel, which sells handbags and apparel through wholesale channels; Direct-to-Consumer, which sells footwear, handbags, apparel, and accessories through stores, outlets, e-commerce, and concessions; and Licensing, which licenses Steve Madden, Betsey Johnson, and Kurt Geiger trademarks, with the Company generating the majority of its revenue from the USA.